Physical Activity Interventions and Their Effects on Cognitive Function in People with Dementia: A Systematic Review and Meta-Analysis.

cognitive function dementia physical activity

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
19 08 2021
Historique:
received: 01 07 2021
revised: 16 08 2021
accepted: 17 08 2021
entrez: 27 8 2021
pubmed: 28 8 2021
medline: 1 9 2021
Statut: epublish

Résumé

Physical activity (PA) has emerged as an alternative nonpharmacological approach to effectively address the effects of dementia. The primary aim was to identify and summarize PA interventions and their effects on cognitive function among persons with dementia (PwD). A systematic review was conducted with a meta-analysis using different electronic databases, such as PubMed, Embase, APA PsycNET, and the Web of Science. The identified and selected studies were randomized controlled trials (RCTs) that were written in English, published between 2000 and 2020, and implemented among PwD who received a PA intervention and whose cognitive function was measured at baseline and during a follow-up. Twenty-two PA intervention studies met the eligibility criteria and showed a medium-size effect on the cognitive function of PwD, 0.4803 (95% CI = 0.1901-0.7704), with a high percentage of heterogeneity (I It is not yet possible to draw a conclusion on the ideal PA intervention for this population due to the high proportion of heterogeneity within the included studies. More emphasis is needed on the intensity of PA monitoring and adherence to such programs.

Sections du résumé

BACKGROUND
Physical activity (PA) has emerged as an alternative nonpharmacological approach to effectively address the effects of dementia. The primary aim was to identify and summarize PA interventions and their effects on cognitive function among persons with dementia (PwD).
METHODS
A systematic review was conducted with a meta-analysis using different electronic databases, such as PubMed, Embase, APA PsycNET, and the Web of Science. The identified and selected studies were randomized controlled trials (RCTs) that were written in English, published between 2000 and 2020, and implemented among PwD who received a PA intervention and whose cognitive function was measured at baseline and during a follow-up.
RESULTS
Twenty-two PA intervention studies met the eligibility criteria and showed a medium-size effect on the cognitive function of PwD, 0.4803 (95% CI = 0.1901-0.7704), with a high percentage of heterogeneity (I
CONCLUSION
It is not yet possible to draw a conclusion on the ideal PA intervention for this population due to the high proportion of heterogeneity within the included studies. More emphasis is needed on the intensity of PA monitoring and adherence to such programs.

Identifiants

pubmed: 34444501
pii: ijerph18168753
doi: 10.3390/ijerph18168753
pmc: PMC8394441
pii:
doi:

Types de publication

Journal Article Meta-Analysis Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Références

Am J Geriatr Psychiatry. 2015 Nov;23(11):1106-16
pubmed: 25648055
Int J Sports Med. 2008 Jun;29(6):471-4
pubmed: 18050054
J Sci Med Sport. 2016 Apr;19(4):293-8
pubmed: 26087884
J Alzheimers Dis. 2017;60(1):323-332
pubmed: 28800328
Contemp Nurse. 2006 Feb-Mar;21(1):32-40
pubmed: 16594879
Rambam Maimonides Med J. 2012 Oct 31;3(4):e0026
pubmed: 23908850
J Am Geriatr Soc. 2016 Apr;64(4):731-8
pubmed: 27037872
J Neurol Neurosurg Psychiatry. 2009 Jul;80(7):802-4
pubmed: 19531688
Lancet. 2017 Dec 16;390(10113):2673-2734
pubmed: 28735855
Worldviews Evid Based Nurs. 2004;1(3):176-84
pubmed: 17163895
Cochrane Database Syst Rev. 2015 Apr 15;(4):CD006489
pubmed: 25874613
Dement Geriatr Cogn Disord. 2018;46(1-2):60-80
pubmed: 30145595
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Am J Geriatr Psychiatry. 2014 Jan;22(1):63-74
pubmed: 23582750
J Alzheimers Dis. 2017;57(3):845-856
pubmed: 28304298
J Intern Med. 2014 Mar;275(3):229-50
pubmed: 24605807
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Expert Rev Neurother. 2008 Jan;8(1):133-58
pubmed: 18088206
Am J Alzheimers Dis Other Demen. 2011 Aug;26(5):381-8
pubmed: 21852281
Alzheimers Res Ther. 2019 Jan 5;11(1):3
pubmed: 30611286
Clin Rehabil. 2008 Jul;22(7):618-26
pubmed: 18586813
J Neurol Sci. 2009 Aug 15;283(1-2):99-106
pubmed: 19264328
Arch Gerontol Geriatr. 2014 Sep-Oct;59(2):195-203
pubmed: 25034708
Dement Geriatr Cogn Disord. 2014;38(5-6):347-65
pubmed: 25171577
Arch Med Res. 2012 Nov;43(8):615-21
pubmed: 23085449
J Geriatr Phys Ther. 2011 Jul-Sep;34(3):138-47
pubmed: 21937904
Lancet Neurol. 2011 Sep;10(9):819-28
pubmed: 21775213
Dement Geriatr Cogn Disord. 2010;29(2):109-14
pubmed: 20150731
Lancet. 1982 Nov 27;2(8309):1200-4
pubmed: 6128503
Neurology. 2014 Nov 4;83(19):1753-60
pubmed: 25298312
Int J Behav Nutr Phys Act. 2020 Feb 5;17(1):12
pubmed: 32024526
J Formos Med Assoc. 2009 Oct;108(10):754-64
pubmed: 19864195
Clin Interv Aging. 2018 Sep 04;13:1593-1603
pubmed: 30233156
Behav Neurol. 2020 Feb 12;2020:7807856
pubmed: 32104516
Dement Geriatr Cogn Dis Extra. 2016 Jun 10;6(2):222-32
pubmed: 27403134
J Alzheimers Dis. 2019;72(3):947-956
pubmed: 31743998
Behav Brain Res. 2009 Jan 23;196(2):271-8
pubmed: 18926856
Int J Geriatr Psychiatry. 2009 Jul;24(7):680-5
pubmed: 19089875
Scand J Caring Sci. 2012 Mar;26(1):12-9
pubmed: 21564154
Clin Rehabil. 2004 May;18(3):253-60
pubmed: 15137556
Neurology. 1984 Jul;34(7):939-44
pubmed: 6610841
Int J Geriatr Psychiatry. 2015 Mar;30(3):234-46
pubmed: 25504093
J Gerontol A Biol Sci Med Sci. 2016 Nov;71(11):1451-1458
pubmed: 27154905
Neural Plast. 2018 Mar 11;2018:9234105
pubmed: 29713339
J Cereb Blood Flow Metab. 2016 Jan;36(1):172-86
pubmed: 26174330
Scand J Med Sci Sports. 2014 Feb;24(1):1-10
pubmed: 23600729
J Alzheimers Dis. 2010;20(3):777-83
pubmed: 20182027
BMC Geriatr. 2016 Jul 18;16:141
pubmed: 27431673
BMC Geriatr. 2019 Jul 2;19(1):181
pubmed: 31266451
Arch Gerontol Geriatr. 2016 Sep-Oct;66:109-18
pubmed: 27295140
Public Health Rep. 1956 Dec;71(12):1179-84
pubmed: 13389686
Int Psychogeriatr. 2014 Jan;26(1):9-18
pubmed: 23962667
Health Technol Assess. 2018 May;22(28):1-202
pubmed: 29848412
CNS Neurol Disord Drug Targets. 2015;14(10):1292-7
pubmed: 26556080

Auteurs

Maria Isabel Cardona (MI)

Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Site Rostock/Greifswald, Ellernholzstr. 1-2, 17489 Greifswald, Germany.

Adel Afi (A)

Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Site Rostock/Greifswald, Ellernholzstr. 1-2, 17489 Greifswald, Germany.

Nemanja Lakicevic (N)

Sport and Exercise Sciences Research Unit, University of Palermo, 90133 Palermo, Italy.

Jochen René Thyrian (JR)

Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Site Rostock/Greifswald, Ellernholzstr. 1-2, 17489 Greifswald, Germany.
Institute for Community Medicine, University Medicine Greifswald, Ellernholzstraße 1-2, 17489 Greifswald, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH